1 recruiting, 1 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 1, Terminated 1, Unknown 1 |
Follow Pt: new trials by email Literature Review of Pt trials Research Report on Pt
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial Biospecimen Collection, Computed Tomography, Cystectomy - Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma | Phase 4 | Recruiting | Mayo Clinic | 75 | 2025-01-08 | 2026-10-01 |
| Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD). Compound Ipratropium Bromide Solution(C1) for Inhalation, Compound Sodium Chlolate and Aminophylline Tablets(C2), Placebo Tablets - Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 200 | 2019-04-01 | 2019-09-24 |
| Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN® APOKYN, Physical Therapy - Parkinson's Disease, Motor Symptoms | Phase 4 | Terminated | MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | 13 | 2016-01-01 | 2023-09-01 |
Parkinson Disease (1) · Ureteral Neoplasms (1) · Urinary Bladder Neoplasms (1)
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals (1) · Mayo Clinic (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
United States (2) · China (1)
Jacob J. Orme, MD, PhD (1) · Mark Pirner, MD (1) · Paras H. Shah, MD (1) · Yang Jin (1)